Drugs / Vapocoolant spray
Vapocoolant spray
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT06023368 | Dec 2023 → Jun 2024 | childhood malignant neoplasm | Marianne Hutti | Withdrawn | No outcome recorded |
| Phase 4 | NCT04207710 | Jan 2021 → Feb 2022 | — | Henry Ford Health System | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01860248 | May 2012 → Jun 2013 | — | Tehran University of Medical Sciences | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01006187 Comparator | Oct → Nov 2009 | anxiety | The Hospital for Sick Children | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vapocoolant spray | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01860248 ↗ |
| Known as | Num Vapocoolant Spray | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06023368 ↗ |
| Known as | Pain Ease | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04207710 ↗ |
| Modality | Other / unclassified | “Topical refrigerant spray” NCT04207710 ↗ |
| Route | Topical | “topical alkane vapocoolant spray” NCT01860248 ↗ |